206 related articles for article (PubMed ID: 31780613)
1. Subacute cutaneous lupus erythematosus with a possible paraneoplastic association with melanoma.
Hirner J
BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31780613
[TBL] [Abstract][Full Text] [Related]
2. [Paraneoplastic subacute cutaneous lupus erythematosus].
Rezazadegan R; Koushk-Jalali B; Kuntz T; Oellig F; Tigges C; Kreuter A
Z Rheumatol; 2021 Mar; 80(2):189-193. PubMed ID: 33236165
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic subacute cutaneous lupus erythematosus: an underrecognized entity.
Evans KG; Heymann WR
Cutis; 2013 Jan; 91(1):25-9. PubMed ID: 23461055
[TBL] [Abstract][Full Text] [Related]
4. Subacute cutaneous lupus erythematosus: a paraneoplastic dermatosis?
Chaudhry SI; Murphy LA; White IR
Clin Exp Dermatol; 2005 Nov; 30(6):655-8. PubMed ID: 16197381
[TBL] [Abstract][Full Text] [Related]
5. Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapy.
Marano AL; Clarke JM; Morse MA; Shah A; Barrow W; Selim MA; Hall RP; Cardones AR
Br J Dermatol; 2019 Sep; 181(3):580-583. PubMed ID: 30244487
[TBL] [Abstract][Full Text] [Related]
6. Subacute cutaneous lupus erythematosus: A facultative paraneoplastic dermatosis.
Lazar AL
Clin Dermatol; 2022; 40(6):728-742. PubMed ID: 35907579
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors-related subacute cutaneous lupus erythematosus: Clinical characteristics, management, and outcome.
Deng Z; Guo A; Wu C; Wang C
J Cosmet Dermatol; 2022 Dec; 21(12):7202-7208. PubMed ID: 36214602
[TBL] [Abstract][Full Text] [Related]
8. Subacute cutaneous lupus erythematosus induced and exacerbated by proton pump inhibitors.
Almebayadh M; Regnier-Rosencher E; Carlotti A; Goulvestre C; Le Guern V; Mouthon L; Avril MF; Dupin N
Dermatology; 2013; 226(2):119-23. PubMed ID: 23548825
[TBL] [Abstract][Full Text] [Related]
9. Subacute Cutaneous Lupus as a Paraneoplastic Manifestation of Non-Hodgkin Lymphoma.
Khokher W; Cash A; Alom M; Iftikhar S; Kesireddy N; Abuhelwa Z; Malik A; Lynn A; Altorok N
J Investig Med High Impact Case Rep; 2022; 10():23247096211063066. PubMed ID: 35225037
[TBL] [Abstract][Full Text] [Related]
10. [Capecitabine-induced subacute cutaneous lupus: a case report].
Fongue J; Meunier B; Lardet D; Dicostanzo MP; Rouby F; Terrier JP; Harlé JR; Richard MA; Chiche L
Ann Dermatol Venereol; 2014 Oct; 141(10):593-7. PubMed ID: 25288062
[TBL] [Abstract][Full Text] [Related]
11. Subacute cutaneous lupus erythematosus as a rare complication of disease-modifying therapy administration in multiple sclerosis: case report.
Xu K; Zhang M; Yang S; Yu G; Zheng P; Qin X; Feng J
BMC Neurol; 2023 Apr; 23(1):168. PubMed ID: 37101279
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced subacute cutaneous lupus erythematosus associated with abatacept.
Figueredo Zamora E; Callen JP; Schadt CR
Lupus; 2021 Apr; 30(4):661-663. PubMed ID: 33349110
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitor induced subacute cutaneous lupus erythematosus: Clinical characteristics and outcomes.
Poh YJ; Alrashid A; Sangle SR; Higgins E; Benton E; McGibbon D; D'Cruz DP
Lupus; 2022 Aug; 31(9):1078-1083. PubMed ID: 35635045
[TBL] [Abstract][Full Text] [Related]
14. Subacute cutaneous lupus erythematosus presenting as erythroderma.
Kalavala M; Shah V; Blackford S
Clin Exp Dermatol; 2007 Jul; 32(4):388-90. PubMed ID: 17459074
[TBL] [Abstract][Full Text] [Related]
15. Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE).
Tiao J; Feng R; Carr K; Okawa J; Werth VP
J Am Acad Dermatol; 2016 May; 74(5):862-9. PubMed ID: 26897388
[TBL] [Abstract][Full Text] [Related]
16. [Subacute cutaneous lupus erythematosus].
Jore S; Gran JT
Tidsskr Nor Laegeforen; 1997 May; 117(14):2040-2. PubMed ID: 9235684
[TBL] [Abstract][Full Text] [Related]
17. Subacute cutaneous lupus erythematosus associated with hepatocellular carcinoma.
Ho C; Shumack SP; Morris D
Australas J Dermatol; 2001 May; 42(2):110-3. PubMed ID: 11309033
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic subacute cutaneous lupus erythematosus associated with cholangiocarcinoma.
Jenkins D; McPherson T
Australas J Dermatol; 2016 Feb; 57(1):e5-7. PubMed ID: 25367767
[TBL] [Abstract][Full Text] [Related]
19. [Subacute cutaneous lupus erythematosus and cancer: two cases and literature review].
Gantzer A; Regnier S; Cosnes A; Ortonne N; Wolkenstein P; Bagot M; Duong TA
Ann Dermatol Venereol; 2011 May; 138(5):409-17. PubMed ID: 21570567
[TBL] [Abstract][Full Text] [Related]
20. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications.
Chlebus E; Wolska H; Blaszczyk M; Jablonska S
J Am Acad Dermatol; 1998 Mar; 38(3):405-12. PubMed ID: 9520021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
